Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.

@article{Wasiak2004BotulinumTA,
  title={Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.},
  author={Jason Wasiak and Brian Hoare and Margaret Wallen},
  journal={The Cochrane database of systematic reviews},
  year={2004},
  volume={3},
  pages={CD003469}
}
BACKGROUND Cerebral palsy (CP) is a central nervous system deficit resulting from a non-progressive lesion in the developing brain. Although the brain lesions are static, the movement disorders that arise are not unchanging and are characterised by atypical muscle tone, posture and movement (Rang 1990). The spastic motor type is the most common form of CP and its conventional therapeutic management may include splinting/casting, passive stretching, facilitation of posture and movement… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

Cerebral palsy of the elbow and forearm.

The Journal of hand surgery • 2014
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-6 of 6 references

Botulinum toxin A in cerebral palsy: functional outcomes.

The Journal of pediatrics • 2000
View 4 Excerpts
Highly Influenced

Scales: Their clinical relevance for measuring spasticity in adult and paediatric neurological populations

Morris 2002 Morris S. Ashworth, Tardieu
Physical Therapy Reviews • 2002

A Physiological Approach to Clinical Neurology

Anne J. Molloy
The Ulster Medical Journal • 1970

Similar Papers

Loading similar papers…